Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 1, 2007, Pages 16-21

  Stenvall, Harriet ^a   Wikström, Ingrid ^a   Backlund, Ingrid ^a   Wilander, Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervix; HPV test; PCR; Screening; Self sampling; Smear; Vagina

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DEVICE; DNA DETERMINATION; FEMALE; HUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SELF CARE; SWEDEN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33845756666     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340601033667     Document Type: Article

References (26)

1. Socialstyrelsen. Sos-rapport: Gynekologisk cellprovskontroll - Förslag till screeningprogram [The National Board of Health and Welfare. Report: Cytological Screening for Cervical Cancer - Screening Programme Suggestion] (In Swedish). Article number 1998-3-15, The National Board of Health and Welfare.
2. Kumar V, Cotrans R, Robbins S. Female genital system and breast. In: Basic Pathology: Female Genital System and Breast. Philadelphia: WB Saunders; 2003. p. 686-9.
3. Walboomers JM, Jacobs MV, Manos M, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9.
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796-802.
5. Wright T, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283:81-6.
6. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening. JAMA. 2000;283:87-93.
7. Solomon D, Schiffman M, Tarone R, ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9.
8. Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol. 2003;69:118-21.
9. Jansson Å, Gustafsson M, Wilander E. Efficiency of cytological screening for detection of cervical squamous carcinoma. Ups J Med Sci. 1998;103:147-54.
10. Stenkvist B, Söderstrom J. Reasons for cervical cancer despite extensive screening. J Med Screen. 1996;3(4):204-7.
11. Digene Corporation. Hybrid Capture Technology HC2. Available on WWW at: http:/www.digene.com. Accessed July 20, 2005.
12. Bauer H, Greer C, Manos M. Determination of genital Human papillomavirus infection by consensus PCR amplification. In: Herrington CS, McGee JO'D, editors. Diagnostic Molecular Pathology. A Practical Approach. Oxford, UK: IRL Press; 1992. p. 131-52.
13. Applied Biosystems. AmpErase® Uracil N-glycosylase (UNG). On WWW at http:/www.appliedbiosystems.com. Accessed July 20, 2005.
14. Zehbe I. New Molecular Biological Methods for Detecting Human Papillomaviral Nucleic Acids in Cells and Tissue Sections. Uppsala: Uppsala University; 1995. p. 18-29.
15. Brown TA. Genetics, A Molecular Approach, 2nd edition. London: Chapman & Hall, 1992: Chapter 21.
16. Brown TA. Gene Cloning, 3rd edition. London: Chapman & Hall, 1995: 183-200, 228-49.
17. Gunnarson R. Kappakoefficient. Department of Primary Health Care, Göteborg University - Research methodology web site. On WWW at http:/infovoice.se/fou/bok/statmet/10000045.htm. Accessed December 2, 2004.
18. Forslund O, Antonsson A, Edlund K, van der Brule AJ, Hansson BG, Meijer CJ, et al. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol. 2002;67:535-41.
19. Bosch FX, de Sanjosé S, Castellsagué X, Moreno V, Muñoz N. Epidemiology of human papillomavirus infections and associations with cervical cancer: new opportunities for prevention. In: Saveria Campo M, editor. Papillomavirus Research: From Natural History to Vaccines and Beyond. England: Caister Academic Press; 2006. p. 19-39.
20. Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med. 2001;32:482-91.
21. Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:346-54.
22. Stenvall H, Wikström I, Wilander E. Human papilloma virus testing of vaginal smear obtained with a novel self-sampling device. Acta Derm Venereol. 2006;86(5):465-7.
23. Nobbenhuis MA, Helmerhorst TJ, van der Brule AJ, Roozendaal L, Bezemer PD, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol. 2002;55:435-9.
24. Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Kornegat JR, Greenberg MD, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev. 2001;10(2):95-100.
25. Harper DM, Hildesheim A, Cobb JL, Greenberg M, Vaught J, Lorincz AT. Collection devises for human papillomavirus. J Fam Pract. 1999;48(7):531-5.
26. Sellors JW, Lorincz AT, Mahony JB, Mielynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ. 2000;163(5):513-8.